NeoLSD MSMS Kit - Taiwan Registration c9a8b4e975a75ffc1290c026b569b5bc
Access comprehensive regulatory information for NeoLSD MSMS Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c9a8b4e975a75ffc1290c026b569b5bc and manufactured by WALLAC OY. The authorized representative in Taiwan is FENG CHI BIOTECH CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
c9a8b4e975a75ffc1290c026b569b5bc
Ministry of Health Medical Device Import No. 030540
DHA05603054003
Product Details
For the quantification of acid-ฮฒ-galactocerebrosidase (ABG), acid-sphingomyelinase (ASM), acid-ฮฑ-glucosidase (GAA), ฮฒ-galactocerebrodidase (GALC), ฮฑ-galactosidase A (GLA), ฮฑ-L-iduronidase ( IDUA). Analysis of prospect enzyme activity can help neonates to screen for lysosomal storage disorder (LSD), including Gaoxue syndrome, Niemann-Pick disease, Pompe disease, Krabbe syndrome, Fabry's disease and mucopolysaccharide I.
B Hematology and pathology devices
B4020 Analyze specific reagents
Imported from abroad
Dates and Status
Apr 19, 2018
Apr 19, 2028